Francesco Cottone

Patient-reported uitkomsten in newly diagnosed patiënten met FLT3-internal-tandem-duplication-positive acute myeloid leukaemia receiving standard chemotherapy plus quizartinib or placebo (QuANTUM-First): a global, randomised, placebo-controlled, phase 3 trial

Patient-reported outcomes in newly diagnosed patiënten met FLT3-internal-tandem-duplication-positive acute myeloid le...

T-DXd versus physician's choice bij HER2-positief mammacarcinoom: DESTINY-Breast02 langetermijn